CNPase Recombinant Antibody
Product Specifications
Background
Predicted to enable 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity. Involved in substantia nigra development. Located in several cellular components, including extracellular space; microtubule; and plasma membrane. Implicated in hypomyelinating leukodystrophy 20; multiple sclerosis; and schizophrenia. Biomarker of alcoholic liver cirrhosis; multiple sclerosis; and restless legs syndrome. [provided by Alliance of Genome Resources, Nov 2021]
Synonyms
2',3'-cyclic-nucleotide 3'-phosphodiesterase; CNPase; Cnp; Cnp-1; Cnp1; 2''; 2'3' cyclic nucleotide 3' phosphodiesterase; 2'3'-cyclic-nucleotide 3'-phosphodiesterase; 3''-cyclic-nucleotide 3''-phosphodiesterase; CN37_HUMAN; CNP 1; CNP; CNP1.
Gene ID
1267
Swiss Prot
P09543
Cellular Locus
Cytoplasm
Host
Mouse
Cross Reactivity
Human, Rat
Target
CNPase
Clonality
Recombinant
Conjugation
Unconjugated
Source
KLH conjugated synthetic peptide derived from human CNPase
Applications
WB, IHC-P, IHC-F, IF, ICC/IF
Purification
Purified by Protein G.
Concentration
1mg/ml
Dilution
WB (WB (1:500-2000) ), IHC-P (ICC (1:50) ), IHC-F (IF (1:100-500) ), IF (), ICC/IF (1:50-100)
Buffer
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Modification
Unmodified
Storage Conditions
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Gene ID URL
1267
Isotype
IgG1/Kappa
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items